10 — VC Portfolio Legal Shield Coming soon

Protect your portfolio before
the next round reveals what you missed.

Series B due diligence is exposing IP gaps, MSA issues, and data privacy failures that were invisible at seed. One portfolio company's legal mess can contaminate an entire fund raise — and it's preventable.

Order this report → From $1,500 · 48h delivery

The Problem

The legal risk that was invisible at seed becomes a due diligence problem at Series B — and it's not just one company's problem.

VC and accelerator portfolios with LatAm exposure are increasingly encountering the same pattern: companies that closed seed and Series A rounds without addressing IP, MSA, or data privacy compliance are hitting walls at Series B when institutional investors run deeper due diligence.

The problem compounds at the portfolio level. One company's unresolved legal issue raises questions about the fund's overall portfolio hygiene standards — and sophisticated Series B lead investors are asking those questions explicitly.

The VC Portfolio Legal Shield provides a standardized legal health assessment across your LatAm-exposed portfolio companies — so you can identify and remediate issues before they surface in a due diligence process you can't control.

What This Product Will Include

Portfolio-level legal intelligence, company by company.

Standardized legal health scorecard per portfolio company (IP, MSA, privacy)

Series B readiness assessment — flag issues before the investor does

LatAm-specific risk screening for IP, MSA regulatory gaps, and data privacy

Remediation roadmap per company — prioritized by deal impact and cost to fix

Portfolio-level summary report for LP or co-investor reporting

Ongoing monitoring option — quarterly legal health updates as companies scale

Pricing

Choose your scope.

Starter

$1,500/mo

Monthly retainer

— Up to 3 portfolio companies
— Legal health scorecard per company
— IP + MSA risk screening
— Quarterly summary report

Order this report →

Standard

Be first to know when this launches.

Leave your details and tell me about your portfolio's LatAm exposure. You'll get early access and priority onboarding when the VC Portfolio Legal Shield is available.

Who This Is For

For VCs and accelerators with LatAm portfolio exposure.

VC funds with 3+ portfolio companies operating in LatAm markets

If multiple portfolio companies have LatAm operations, a standardized legal health protocol protects the fund's reputation and gives you a defensible answer when institutional LPs ask about portfolio compliance.

Accelerators running LatAm-focused cohorts

A structured legal health assessment at cohort graduation sets your companies up for their next raise — and differentiates your program from accelerators that only address legal compliance reactively.

US-based VCs preparing portfolio companies for Series B with LatAm market traction

If your portfolio companies have LatAm revenue and are preparing for institutional rounds, Series B investors will run deeper legal due diligence than anything they've seen before. This product helps you anticipate and prepare for those questions.